Argon Gas Specifications

Cardioblate® CryoFlex ™

surgical ablation system

Guidelines and Specifications for Argon Gas with the

Cardioblate® CryoFlex™ Argon-Powered Surgical Ablation System
The Cardioblate CryoFlex Argon-Powered Surgical Ablation System uses argon refrigerant for rapid ablation.
Argon gas and tank must meet the following specifications for proper function of the Cardioblate CryoFlex
Argon-Powered Surgical Ablation System.

Argon Gas Specifications

Argon Grade North America Europe
Prepurified Argon Prepurified Argon
> 99.998% pure (grade 4.8) > 99.998% pure (grade 4.8)

(Maximum acceptable level of impurity: 20 ppm)

Tank Pressure 6000 psi 310 Bar/31,000 Kpa

Tank Volume ~ 50 liters 50 liters
Tank Diameter 10 inches 25.4 cm
Tank Height* 56 inches 122 cm
Tank Valve Fitting CGA677 or CGA680 CEN 1 (Argon)
W30 mm x 2 mm
Cryo Time per Cylinder ~ 70 minutes ~ 35 minutes

*Includes cylinder cap and valve

Note: When the tank depletes to 3,000 psi/210 Bar/21,000 Kpa, it is no longer useful and should be changed.
Argon gas tanks are refilled by local gas suppliers of the hospital’s choice.

UC201105524 EN © Medtronic, Inc. 2011. All Rights Reserved. Printed in USA

www.medtronic.com
World Headquarters LifeLine The Cardioblate CryoFlex Surgical Ablation System
Medtronic, Inc. CardioVascular Technical Support Indications for Use: is intended for minimally invasive cardiac surgical procedures, including the treatment
of cardiac arrhythmias. The Cardioblate CryoFlex 7cm, 10cm, and 10-S probes plus the Cardioblate CryoFlex
710 Medtronic Parkway Tel: (877) 526-7890 Clamp and Cardioblate CryoFlex Surgical Ablation Console freeze target tissue and block the electrical
Minneapolis, MN 55432-5604 Tel: (763) 526-7890 conduction pathways by creating an inflammatory response and cryonecrosis. Contraindications: The
USA Fax: (763) 526-7888 Cardioblate CryoFlex Surgical Ablation Probe is not designed for use inside a beating heart. Adverse Events
Tel: (763) 514-4000 E-mail: rs.cstechsupport@medtronic.com or Complications: Potential adverse events with this device are similar to other cardiac surgery procedures
and may include the following: Bleeding; re-operation; extension of extracorporeal bypass; heart rhythm
Fax: (763) 514-4879 disturbances (atrial and/or ventricular); effusion; pericarditis; cardiac tamponade; pleural effusion;
mediastinitis; conduction disturbances (SA/AV node); acute ischemic myocardial event; thrombus formation;
Medtronic USA, Inc. low cardiac output; stroke; renal, gastrointestinal or respiratory complications; sepsis; adjacent structural
Toll-free: 1 (800) 328-2518 damage; and death.
(24-hour technical support for • Avoid contact between the cryoablation probe and the phrenic nerve to avoid injury. Perioperative heart
physicians and medical professionals) rhythm disturbances (atrial and/or ventricular)
• Cryoablation involving coronary vessels has been associated with subsequent clinically significant arterial
stenosis. It is unknown whether Cryoablation with the Cardioblate CryoFlex Surgical Ablation Probe will
have such an effect, but as in all such procedures, care should be taken to minimize unnecessary contact
with coronary vessels during Cryoablation.
Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. For a complete
listing of all indications, contraindications, precautions and warnings, please refer to the Instructions for
Use which accompany each product.

Cardioblate is a registered trademark of Medtronic, Inc. CryoFlex is a trademark of Medtronic, Inc.